Unraveling the Challenges in the Generic Drug Industry

This chapter explores the challenges facing the generic drug industry, including shortages and heightened competition. It examines the historical roots of these issues, particularly the effects of the Hatch-Waxman Act of 1984, and prepares listeners for deeper insights into the pharmaceutical landscape and its impact on healthcare access.